Effect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling.

Karaca, BBozkurt, EAtmaca, RSurmeli, ZPinar, ASanil, UAUslu, R2025-04-102025-04-100732-183Xhttp://hdl.handle.net/20.500.14701/38393EnglishEffect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling.Meeting Abstract1527-7755